DefiniensAG

Definiens, the company’s mission is to help scientists leverage tissue-based omics to accelerate the development of targeted drugs for IO therapies® Deepen the understanding of disease biology and immune system mechanisms, and contextualize multi-omics data for cancer-related insights to facilitate the translation of new findings into novel therapies and treatment strategies.